WeVote

Bill

Bill

SB 1094

Prescription drugs.

2025-2026 Regular Session Introduced by Akilah Weber Pierson

California bill SB 1094 addresses prescription drugs; full details pending committee review and bill text publication.

Set for hearing May 4.
0
WeVote Research Nonpartisan
Bill Summary · SB 1094

Legislative bill overview

SB 1094 is a California prescription drug bill introduced by Senator Akilah Weber Pierson. The bill was recently printed and is currently in the Rules Committee awaiting assignment to substantive committees. Specific provisions are not yet publicly available as the bill has only just entered the legislative process.

Why is this important

Prescription drug policy directly affects healthcare affordability and access for millions of Californians. Drug-related legislation can influence pricing, insurance coverage, pharmaceutical industry practices, and patient outcomes, making it a high-impact policy area with broad public interest.

Potential points of contention

  • Drug pricing mechanisms – Any provisions affecting pricing could face opposition from pharmaceutical manufacturers versus patient advocacy groups seeking affordability
  • Insurance coverage requirements – Mandates on which drugs insurers must cover may conflict with industry concerns about cost containment
  • Implementation scope – Whether the bill applies to public programs (Medi-Cal), private insurance, or both will determine its reach and financial impact

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.